Harbourvest Partners LLC Rapt Therapeutics, Inc. Transaction History
Harbourvest Partners LLC
- $215 Million
- Q1 2024
Shares
3 transactions
Others Institutions Holding RAPT
# of Institutions
147Shares Held
29.2MCall Options Held
709KPut Options Held
1.06M-
Column Group LLC San Francisco, CA2.68MShares$7.48 Million15.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$6.96 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$6.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.03MShares$5.66 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.91MShares$5.32 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $82.7M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...